Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents

Abstract Background There has not been sufficient data to evaluate the serial vascular healing pattern after everolimus-eluting stent (EES) implantation. Using optical coherence tomography, we compared serial changes in strut coverage of the EES and the first-generation sirolimus-eluting stent (SES)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of cardiology 2015-06, Vol.31 (6), p.723-730
Hauptverfasser: Kim, Jung-Sun, MD, Kim, Jeong Hun, MD, Shin, Dong-Ho, MD, Kim, Byeong-Keuk, MD, Ko, Young-Guk, MD, Choi, Donghoon, MD, Jang, Yangsoo, MD, Hong, Myeong-Ki, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 730
container_issue 6
container_start_page 723
container_title Canadian journal of cardiology
container_volume 31
creator Kim, Jung-Sun, MD
Kim, Jeong Hun, MD
Shin, Dong-Ho, MD
Kim, Byeong-Keuk, MD
Ko, Young-Guk, MD
Choi, Donghoon, MD
Jang, Yangsoo, MD
Hong, Myeong-Ki, MD
description Abstract Background There has not been sufficient data to evaluate the serial vascular healing pattern after everolimus-eluting stent (EES) implantation. Using optical coherence tomography, we compared serial changes in strut coverage of the EES and the first-generation sirolimus-eluting stent (SES). Methods Sixty patients were randomly assigned to receive either EES (n = 30) or first-generation SES (n = 30) for coronary artery disease. Serial optical coherence tomography evaluation immediately after the procedure, and 3- and 12-month follow-ups were performed in 50 patients with 54 stents (25 patients with 28 EES vs 25 patients with 26 SES). The percentage of uncovered struts was defined as the ratio of uncovered struts to total struts. The primary end point was the percentage of uncovered struts at 12-month follow-up. The secondary primary end point was the percentage of uncovered struts at the 3-month follow-up and the comparative percentage change (Δ) of uncovered struts at 3- and 12-month follow-ups of EES vs SES. Results The percentage of uncovered struts was significantly lower in the EES group compared with the SES group (median value, 6.9%; interquartile range [IQR], 3.9-10.6% vs 11.1%; IQR, 5.5-29.4%, respectively) at the 3-month follow-up ( P  = 0.03), and at the 12-month follow-up (median value, 1.3%; IQR, 0.3-3.5% vs 3.6%; IQR, 1.0-9.4%; P  = 0.02). The percentage Δ of uncovered struts from the 3- to the 12-month follow-up was similar (−7.0 ± 6.9% in EES vs −10.5 ± 13.6% in SES; P  = 0.24). Conclusions The EES group showed more favourable stent strut coverage than the first-generation SES group at the early and late periods after stent implantation. These findings suggest that EES have a more beneficial effect for vascular healing.
doi_str_mv 10.1016/j.cjca.2015.01.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1684429488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X15000240</els_id><sourcerecordid>1684429488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-d3c3610244df1c13fdbf8a44d0a67f36cc26d062cad190be64951d128e968e3</originalsourceid><addsrcrecordid>eNp9kcGK1TAUhoMoznX0BVxIl25az0nbNAUR5HJnFAYE68JdyE1Oh3Ta5pq0A-PTm3JnXLhwleTk_37IF8beIhQIKD4MhRmMLjhgXQAWAPwZ22GLIm-gqZ-zHUgucy75zwv2KsYBoMKmES_ZBa-l5GXZ7NhdR8HpMfuuZ-sn95tstvfTSQcX_Zz5PuuWsC5pdk9B39I2OaStH920xjxLVHblQlzya5pTYnGJ6tzT_WFcFzffphKal_iavej1GOnN43rJuqvDj_2X_Obb9df955vc1FWz5LY0pUDgVWV7NFj29thLnU6gRdOXwhguLAhutMUWjiSqtkaLXFIrJJWX7P259RT8r5XioiYXDY2jnsmvUaGQVcXbSsoU5eeoCT7GQL06BTfp8KAQ1KZYDWpTrDbFClAlxQl699i_Hieyf5Enpynw8Ryg9MZ7R0FF42g2ZF0gsyjr3f_7P_2Dm9HNzujxjh4oDn4Nc7KnUEWuQHXbJ29_jDUkvILyD4X0ovs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1684429488</pqid></control><display><type>article</type><title>Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Jung-Sun, MD ; Kim, Jeong Hun, MD ; Shin, Dong-Ho, MD ; Kim, Byeong-Keuk, MD ; Ko, Young-Guk, MD ; Choi, Donghoon, MD ; Jang, Yangsoo, MD ; Hong, Myeong-Ki, MD</creator><creatorcontrib>Kim, Jung-Sun, MD ; Kim, Jeong Hun, MD ; Shin, Dong-Ho, MD ; Kim, Byeong-Keuk, MD ; Ko, Young-Guk, MD ; Choi, Donghoon, MD ; Jang, Yangsoo, MD ; Hong, Myeong-Ki, MD</creatorcontrib><description>Abstract Background There has not been sufficient data to evaluate the serial vascular healing pattern after everolimus-eluting stent (EES) implantation. Using optical coherence tomography, we compared serial changes in strut coverage of the EES and the first-generation sirolimus-eluting stent (SES). Methods Sixty patients were randomly assigned to receive either EES (n = 30) or first-generation SES (n = 30) for coronary artery disease. Serial optical coherence tomography evaluation immediately after the procedure, and 3- and 12-month follow-ups were performed in 50 patients with 54 stents (25 patients with 28 EES vs 25 patients with 26 SES). The percentage of uncovered struts was defined as the ratio of uncovered struts to total struts. The primary end point was the percentage of uncovered struts at 12-month follow-up. The secondary primary end point was the percentage of uncovered struts at the 3-month follow-up and the comparative percentage change (Δ) of uncovered struts at 3- and 12-month follow-ups of EES vs SES. Results The percentage of uncovered struts was significantly lower in the EES group compared with the SES group (median value, 6.9%; interquartile range [IQR], 3.9-10.6% vs 11.1%; IQR, 5.5-29.4%, respectively) at the 3-month follow-up ( P  = 0.03), and at the 12-month follow-up (median value, 1.3%; IQR, 0.3-3.5% vs 3.6%; IQR, 1.0-9.4%; P  = 0.02). The percentage Δ of uncovered struts from the 3- to the 12-month follow-up was similar (−7.0 ± 6.9% in EES vs −10.5 ± 13.6% in SES; P  = 0.24). Conclusions The EES group showed more favourable stent strut coverage than the first-generation SES group at the early and late periods after stent implantation. These findings suggest that EES have a more beneficial effect for vascular healing.</description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2015.01.002</identifier><identifier>PMID: 25882337</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Age Factors ; Aged ; Angioplasty, Balloon, Coronary - methods ; Cardiovascular ; Coronary Angiography - methods ; Coronary Stenosis - diagnostic imaging ; Coronary Stenosis - mortality ; Coronary Stenosis - therapy ; Drug-Eluting Stents ; Everolimus ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Prospective Studies ; Prosthesis Design ; Regression Analysis ; Risk Assessment ; Severity of Illness Index ; Sex Factors ; Sirolimus - administration &amp; dosage ; Sirolimus - analogs &amp; derivatives ; Survival Analysis ; Treatment Outcome</subject><ispartof>Canadian journal of cardiology, 2015-06, Vol.31 (6), p.723-730</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2015 Canadian Cardiovascular Society</rights><rights>Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-d3c3610244df1c13fdbf8a44d0a67f36cc26d062cad190be64951d128e968e3</citedby><cites>FETCH-LOGICAL-c547t-d3c3610244df1c13fdbf8a44d0a67f36cc26d062cad190be64951d128e968e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0828282X15000240$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25882337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Jung-Sun, MD</creatorcontrib><creatorcontrib>Kim, Jeong Hun, MD</creatorcontrib><creatorcontrib>Shin, Dong-Ho, MD</creatorcontrib><creatorcontrib>Kim, Byeong-Keuk, MD</creatorcontrib><creatorcontrib>Ko, Young-Guk, MD</creatorcontrib><creatorcontrib>Choi, Donghoon, MD</creatorcontrib><creatorcontrib>Jang, Yangsoo, MD</creatorcontrib><creatorcontrib>Hong, Myeong-Ki, MD</creatorcontrib><title>Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description>Abstract Background There has not been sufficient data to evaluate the serial vascular healing pattern after everolimus-eluting stent (EES) implantation. Using optical coherence tomography, we compared serial changes in strut coverage of the EES and the first-generation sirolimus-eluting stent (SES). Methods Sixty patients were randomly assigned to receive either EES (n = 30) or first-generation SES (n = 30) for coronary artery disease. Serial optical coherence tomography evaluation immediately after the procedure, and 3- and 12-month follow-ups were performed in 50 patients with 54 stents (25 patients with 28 EES vs 25 patients with 26 SES). The percentage of uncovered struts was defined as the ratio of uncovered struts to total struts. The primary end point was the percentage of uncovered struts at 12-month follow-up. The secondary primary end point was the percentage of uncovered struts at the 3-month follow-up and the comparative percentage change (Δ) of uncovered struts at 3- and 12-month follow-ups of EES vs SES. Results The percentage of uncovered struts was significantly lower in the EES group compared with the SES group (median value, 6.9%; interquartile range [IQR], 3.9-10.6% vs 11.1%; IQR, 5.5-29.4%, respectively) at the 3-month follow-up ( P  = 0.03), and at the 12-month follow-up (median value, 1.3%; IQR, 0.3-3.5% vs 3.6%; IQR, 1.0-9.4%; P  = 0.02). The percentage Δ of uncovered struts from the 3- to the 12-month follow-up was similar (−7.0 ± 6.9% in EES vs −10.5 ± 13.6% in SES; P  = 0.24). Conclusions The EES group showed more favourable stent strut coverage than the first-generation SES group at the early and late periods after stent implantation. These findings suggest that EES have a more beneficial effect for vascular healing.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Angioplasty, Balloon, Coronary - methods</subject><subject>Cardiovascular</subject><subject>Coronary Angiography - methods</subject><subject>Coronary Stenosis - diagnostic imaging</subject><subject>Coronary Stenosis - mortality</subject><subject>Coronary Stenosis - therapy</subject><subject>Drug-Eluting Stents</subject><subject>Everolimus</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Prosthesis Design</subject><subject>Regression Analysis</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>Sex Factors</subject><subject>Sirolimus - administration &amp; dosage</subject><subject>Sirolimus - analogs &amp; derivatives</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcGK1TAUhoMoznX0BVxIl25az0nbNAUR5HJnFAYE68JdyE1Oh3Ta5pq0A-PTm3JnXLhwleTk_37IF8beIhQIKD4MhRmMLjhgXQAWAPwZ22GLIm-gqZ-zHUgucy75zwv2KsYBoMKmES_ZBa-l5GXZ7NhdR8HpMfuuZ-sn95tstvfTSQcX_Zz5PuuWsC5pdk9B39I2OaStH920xjxLVHblQlzya5pTYnGJ6tzT_WFcFzffphKal_iavej1GOnN43rJuqvDj_2X_Obb9df955vc1FWz5LY0pUDgVWV7NFj29thLnU6gRdOXwhguLAhutMUWjiSqtkaLXFIrJJWX7P259RT8r5XioiYXDY2jnsmvUaGQVcXbSsoU5eeoCT7GQL06BTfp8KAQ1KZYDWpTrDbFClAlxQl699i_Hieyf5Enpynw8Ryg9MZ7R0FF42g2ZF0gsyjr3f_7P_2Dm9HNzujxjh4oDn4Nc7KnUEWuQHXbJ29_jDUkvILyD4X0ovs</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Kim, Jung-Sun, MD</creator><creator>Kim, Jeong Hun, MD</creator><creator>Shin, Dong-Ho, MD</creator><creator>Kim, Byeong-Keuk, MD</creator><creator>Ko, Young-Guk, MD</creator><creator>Choi, Donghoon, MD</creator><creator>Jang, Yangsoo, MD</creator><creator>Hong, Myeong-Ki, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150601</creationdate><title>Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents</title><author>Kim, Jung-Sun, MD ; Kim, Jeong Hun, MD ; Shin, Dong-Ho, MD ; Kim, Byeong-Keuk, MD ; Ko, Young-Guk, MD ; Choi, Donghoon, MD ; Jang, Yangsoo, MD ; Hong, Myeong-Ki, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-d3c3610244df1c13fdbf8a44d0a67f36cc26d062cad190be64951d128e968e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Angioplasty, Balloon, Coronary - methods</topic><topic>Cardiovascular</topic><topic>Coronary Angiography - methods</topic><topic>Coronary Stenosis - diagnostic imaging</topic><topic>Coronary Stenosis - mortality</topic><topic>Coronary Stenosis - therapy</topic><topic>Drug-Eluting Stents</topic><topic>Everolimus</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Prosthesis Design</topic><topic>Regression Analysis</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>Sex Factors</topic><topic>Sirolimus - administration &amp; dosage</topic><topic>Sirolimus - analogs &amp; derivatives</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Jung-Sun, MD</creatorcontrib><creatorcontrib>Kim, Jeong Hun, MD</creatorcontrib><creatorcontrib>Shin, Dong-Ho, MD</creatorcontrib><creatorcontrib>Kim, Byeong-Keuk, MD</creatorcontrib><creatorcontrib>Ko, Young-Guk, MD</creatorcontrib><creatorcontrib>Choi, Donghoon, MD</creatorcontrib><creatorcontrib>Jang, Yangsoo, MD</creatorcontrib><creatorcontrib>Hong, Myeong-Ki, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Jung-Sun, MD</au><au>Kim, Jeong Hun, MD</au><au>Shin, Dong-Ho, MD</au><au>Kim, Byeong-Keuk, MD</au><au>Ko, Young-Guk, MD</au><au>Choi, Donghoon, MD</au><au>Jang, Yangsoo, MD</au><au>Hong, Myeong-Ki, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>31</volume><issue>6</issue><spage>723</spage><epage>730</epage><pages>723-730</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract>Abstract Background There has not been sufficient data to evaluate the serial vascular healing pattern after everolimus-eluting stent (EES) implantation. Using optical coherence tomography, we compared serial changes in strut coverage of the EES and the first-generation sirolimus-eluting stent (SES). Methods Sixty patients were randomly assigned to receive either EES (n = 30) or first-generation SES (n = 30) for coronary artery disease. Serial optical coherence tomography evaluation immediately after the procedure, and 3- and 12-month follow-ups were performed in 50 patients with 54 stents (25 patients with 28 EES vs 25 patients with 26 SES). The percentage of uncovered struts was defined as the ratio of uncovered struts to total struts. The primary end point was the percentage of uncovered struts at 12-month follow-up. The secondary primary end point was the percentage of uncovered struts at the 3-month follow-up and the comparative percentage change (Δ) of uncovered struts at 3- and 12-month follow-ups of EES vs SES. Results The percentage of uncovered struts was significantly lower in the EES group compared with the SES group (median value, 6.9%; interquartile range [IQR], 3.9-10.6% vs 11.1%; IQR, 5.5-29.4%, respectively) at the 3-month follow-up ( P  = 0.03), and at the 12-month follow-up (median value, 1.3%; IQR, 0.3-3.5% vs 3.6%; IQR, 1.0-9.4%; P  = 0.02). The percentage Δ of uncovered struts from the 3- to the 12-month follow-up was similar (−7.0 ± 6.9% in EES vs −10.5 ± 13.6% in SES; P  = 0.24). Conclusions The EES group showed more favourable stent strut coverage than the first-generation SES group at the early and late periods after stent implantation. These findings suggest that EES have a more beneficial effect for vascular healing.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>25882337</pmid><doi>10.1016/j.cjca.2015.01.002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0828-282X
ispartof Canadian journal of cardiology, 2015-06, Vol.31 (6), p.723-730
issn 0828-282X
1916-7075
language eng
recordid cdi_proquest_miscellaneous_1684429488
source MEDLINE; Elsevier ScienceDirect Journals
subjects Age Factors
Aged
Angioplasty, Balloon, Coronary - methods
Cardiovascular
Coronary Angiography - methods
Coronary Stenosis - diagnostic imaging
Coronary Stenosis - mortality
Coronary Stenosis - therapy
Drug-Eluting Stents
Everolimus
Female
Humans
Male
Middle Aged
Multivariate Analysis
Prognosis
Prospective Studies
Prosthesis Design
Regression Analysis
Risk Assessment
Severity of Illness Index
Sex Factors
Sirolimus - administration & dosage
Sirolimus - analogs & derivatives
Survival Analysis
Treatment Outcome
title Serial Randomized Comparison of Strut Coverage of Everolimus- and First-Generation Sirolimus-Eluting Stents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A13%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serial%20Randomized%20Comparison%20of%20Strut%20Coverage%20of%20Everolimus-%20and%20First-Generation%20Sirolimus-Eluting%20Stents&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Kim,%20Jung-Sun,%20MD&rft.date=2015-06-01&rft.volume=31&rft.issue=6&rft.spage=723&rft.epage=730&rft.pages=723-730&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2015.01.002&rft_dat=%3Cproquest_cross%3E1684429488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1684429488&rft_id=info:pmid/25882337&rft_els_id=S0828282X15000240&rfr_iscdi=true